Subgenomic HCV RNA replication and its localization in the nucleus of the infected cells  by Eisa, Zaki Monawar
Saudi Journal of Biological Sciences (2011) 18, 213–218King Saud University
Saudi Journal of Biological Sciences
www.ksu.edu.sa
www.sciencedirect.comORIGINAL ARTICLESubgenomic HCV RNA replication and its localization
in the nucleus of the infected cellsZaki Monawar Eisa *King Fahd Hospital, Gizan, Saudi ArabiaReceived 3 August 2010; revised 30 January 2011; accepted 30 January 2011






Hepatitis C VirusTel.: +966 0505767094.
-mail address: Zaki67@hotm
19-562X ª 2011 King Saud
sevier B.V. All rights reserve






osting by EAbstract Cell culture systems have been established, where a hepatitis C virus (HCV) subgenomic
replicon was efﬁciently replicated and maintained for a long period. It is known that HCV contains
proteins which interact host cell proteins.
To see whether a HCV RNA replicon can interact in the same way with host cell proteins, HCV
RNA replicon was transfected in Huh7 cells. In most infected cells, HCV replicon is present in the
cytoplasm; however, in a minority of HCV-infected cells, both the cytoplasm and the nucleus or the
nucleus on its own is positive for NS3. The presence of NS3 in the nuclei of Huh7 cells indicates that
the protein may play a role other than in virus replication, such as in persistence of HCV infection.
ª 2011 King Saud University. Production and hosting by Elsevier B.V. All rights reserved.1. Introduction
Hepatitis C virus (HCV) was identiﬁed as the causative agent
for most post-transfusion and sporadic non-A, non-B hepatitis
cases in 1989 (Ramadori and Meier, 2001). According to
recent estimates, about 170 million individuals worldwide are
infected and 3–4 million people are newly infected each year
(Cohen, 1999). One important characteristic of HCV is itsy. Production and hosting by
Saud University.
lsevierstrong propensity to persist in the infected individual, which
leads to severe liver damage, ranging from chronic hepatitis
to liver cirrhosis and hepatocellular carcinoma (Khu et al.,
2001). It is a serious infection, affecting 1–2% of the popula-
tion in most developed countries. Around 90% of HCV infec-
tions become chronic, up to 20% of these develop into liver
cirrhosis, and 1–5% of the cases lead to hepatocellular carci-
noma (Lanford et al., 2001). Although treatment of this infec-
tion using interferon-a and ribavirin has been effective in a few
cases (about 40%), more than 60% of the patients, however,
show no response to the treatment. The development of new
antiviral agents against HCV infections has been hampered
by the lack of a cell culture system for propagating the virus
and practical animal model systems.
1.1. Cell Culture Systems
There have been a number of attempts at propagating HCV in
cell culture using different cell lines but this has been difﬁcult
to achieve. Studies have involved infection of primary cell lines
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hepatocytes (Iacovacci et al.,1993, 1997), primary human hepa-
tocytes (Rumin et al., 1999) and primary hepatocytes from chim-
panzees (Lanford et al., 1994), as well as cultivation of infected
cells frompatients harbouring the virus, such as peripheral blood
mononuclear cells (PBMCs) and primary hepatocytes prepared
from liver biopsies (Ito et al., 1996). The experimental infection
of PBMCs has also been reported (Cribier et al., 1995). In addi-
tion to infectionof primary cell lines,HCV inoculationof human
hepatoma cell lines, such as HepG2, Huh7 and PH5CH cells, as
well as, B- and T-cell lines, such as, Molt-4, MT-2 and Daudi
cells, have been studied in detail (Bartenschlager and Lohmann,
2001). Of the cell lines tested the PH5CH cell line appears to
be the most susceptible to HCV infection (Kato et al., 1996).
The problem with these systems is that they are poorly
reproducible and low levels of HCV are present within the cul-
tures, requiring sensitive detection techniques to identify the
virus. Techniques such as RT-PCR, sequencing of the HCV
genome fragments in cells, and the detection of viral antigens
have been used to demonstrate HCV replication within cells
(Bartenschlager and Lohmann, 2001).2. Materials and methods
2.1. Tissue culture materials and reagents
All tissue culture plasticware were purchased from VWR. All
tissue culture reagents were purchased from Invitrogen: RPMI
1640 and media supplements (FCS, glutamine, geneticin, pen-
icillin and streptomycin). Cell lines were maintained in DMEM
growth media supplemented with 2 mM L-glutamine, 10%
Fetal Calf Serum (FCS), 100 International Units/ml penicillin
and 100 lg/ml streptomycin. Inactivation of complement in
FCS was achieved by incubation at 56 C for 60 min.
Replicons were kind gift from Dr. Charles Rice.
2.2. Mammalian cell culture techniques
2.2.1. Maintenance and handling
The cell lines described in the materials were propagated as
follows:
The media incubated with the cells in 75 cm2 (T75) tissue
culture ﬂasks was discarded and cells were washed with 5 ml
of PBS. The PBS was discarded and replaced with 2 ml of tryp-
sin (5·) (Invitrogen) diluted 1/5 in PBS. Thirty millilitres of the
correct tissue culture medium (depending on the cell line) was
added to the trypsinised cells and 10 ml was distributed into
new 75 cm2 tissue culture ﬂasks. Cells were propagated in this
manner every 4–5 days.
2.2.2. Linearization of plasmid DNA
Ten micrograms of each replicon encoding plasmid (Pol, Bart,
A1174T (Rep 3), and S1179I (Rep 4)) was linearized by diges-
tion with Sca1 restriction enzyme for 2 h at 37 C. Each plas-
mid DNA was checked to ensure that complete linearization
had been achieved by agarose gel electrophoresis.
2.3. RNA transcription reaction
Transcription reactions were carried out by using MEGAscript
Kit (Ambion).2.4. RNA transfection
Transfection was carried out in two ways:
2.4.1. Transfection using lipofectin
Twenty-ﬁve microlitres of each RNA sample was mixed with
275 ll of PBS and 30 ll of lipofectin was mixed with 270 ll
of PBS. Then, the RNA mixture was added to lipofectin mix-
ture and incubated on ice for 10 min. The culture medium was
removed from 80% conﬂuent Huh7 cells and they were washed
with 2 ml of PBS. One hundred and ﬁfty microlitres of the
RNA–lipofectin mixture was further diluted in 3 ml of PBS,
was then added to each ﬂask and incubated for 30 min. The
RNA–lipofectin mixture was removed and the cells were
washed with 1 ml of PBS. Ten millilitres of culture medium
was added to the cells and incubated at 37 C for 24 h. The
medium was removed and replaced with new culture medium
containing 0.5 mg/ml of G418. Huh7 cells which had not been
transfected with HCV RNA was also grown in RPMI/G418
medium, as a negative control.
2.4.2. Transfection using electroporation
A 75 cm2 tissue culture ﬂask of 80% conﬂuent Huh7 cells was
washed with 5 ml of PBS and replaced by another 2 ml of
PBS. Two millilitres of trypsin/EDTA (5·) diluted 1/5 in
PBS solution was added to the ﬂask, and incubated for
2 min at 37 C. Ten millilitres of RPMI medium was added
to the ﬂask to stop trypsinization and the cells were then
transferred to a 20 ml tube. Five to ten microlitres of RNA
(10 lg) was added to the cell suspension. The electroporation
apparatus, Gene Pulser (BIO-RAD), was set up to give a
ﬁeld strength of 1.5 kV/cm at 25 lF capacitance. The cuvette
was placed in the electroporator and the cell suspension was
pulsed twice. The cells were placed on ice for 5 min to allow
them to recover. The electroporated cells were transferred to a
new 75 cm2 ﬂask which contained 9.5 ml of RPMI medium.
The ﬂask was incubated at 37 C for 24 h. The following
day, the medium was replaced with 10 ml of RPMI medium
and 0.1 ml of G418 (0.5 mg/ml). A negative control of
untransfected Huh7 cells was also incubated in RPMI/G418
medium.
2.5. In situ protein staining
Glass cover slips were sterilised (dipped in alcohol and ﬂamed)
and placed in the bottom of the wells of Sterilin 6 well plates.
HCV RNA replicon cells were seeded in half of the wells while
the rest of the wells were seeded with Huh7 cells. The cells left
to grow up to 80% conﬂuence.
2.6. Staining of cells to detect HCV NS3
Three millilitres of methanol:acetone mix was added to the
wells which contained growing cells onto cover slips within a
six well plate for a minimum of 1 h at 20 C. The mix was
then removed from the wells and the cells were re-hydrated
by washing with PBS. To block non-speciﬁc binding of anti-
bodies the slides were incubated with 1:25 dilution of swine
normal serum (Dako) for 30 min. The swine serum was dis-
carded and the excess was wiped away. Each of the cover slips
were removed from the corresponding well and placed, cell
coated face down, onto 50 ll of rabbit polyclonal anti-NS3
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sterile PBS at room temperature on a 2 cm by 2 cm square
of paraﬁlm for 30 min. Unbound antibody was washed off
by washing three times in PBS and the coverslips were then
placed face down onto 50 ll of FITC conjugated swine anti-
rabbit antibody (Dako), diluted 1 in 40 in sterile PBS for
30 min. The slide was washed again three times in sterile
PBS, once in water, and placed face down on mounting med-
ium (Vectashield) on a clean microscope slide. The cells were
viewed at 400· magniﬁcation with an inverted microscope.
2.7. DNA gel electrophoresis techniques
2.7.1. Agarose gel electrophoresis of DNA
Agarose gels were formed using a Horizon gel electrophoresis
apparatus (Invitrogen). 0.7–2.0% agarose (w/v) in 1· TAE or
1· TBE buffer was melted in a microwave oven 5 lg/ml
ethidium bromide was added and it was allowed to cool to
65 C and then poured into the assembled apparatus taking
care not to introduce air bubbles.
2.8. Northern blotting
Total RNA was extracted from transfected cells and 5 lg of to-
tal RNA was loaded onto the gel. NS3 probe was puriﬁed by
using MicroSpin G-50 columns (Amersham Pharmacia). Blots
were visualized and quantitated as described (Yang et al.,
2002).Figure 1 Northern blot hybridization of RNA from cells
transfected with replicon RNAs. RNAs resolved by formaldehyde
gel electrophoresis were transferred to a nylon membrane and
Northern blot analysis was carried out using a 32P-labelled DNA
probe corresponding to the NS3 region. X-ray ﬁlm was developed
after 7 days exposure. (1) Untransfected Huh7 cells; (2) Rep 3; (3)
Rep 4. The arrow indicates the position of the HCV replicon RNA
(7990 nucleotides).3. Results
3.1. Transcription of HCV RNA replicon plasmids
To make cell lines in which contain replicating HCV replicon
RNA, it was ﬁrst necessary to produce RNA transcripts from
the RNA replicon plasmids. Ten micrograms of each puriﬁed
plasmid DNA was digested with Sca1 and 0.2 lg samples of
the digested plasmids were run on an agarose gel to ensure that
they were completely linearized.
Replicon RNAs were then produced by transcription of the
linearized plasmids with Sca1. Large scale preparations of
HCV replicon RNAs were carried out by transcription of the
linearized plasmids using the MEGAscript Kit. Approximately
0.2 lg of each RNA transcript were then examined by agarose
gel electrophoresis to ensure that transcripts of the correct size,
7990 nucleotides, had been produced and that there was no
apparent degradation of the RNA.
3.2. Transfection of Huh7 cells with replicon RNAs
RNA transfection of Huh7 cells was carried out by using two
different methods: lipofectin and electroporation. Due to the
presence of G418, only transfected cells will survive in its pres-
ence. Forty-eight hours after both transfection procedures,
dead cells were observed in the tissue culture ﬂasks. Within
2 weeks, all untransfected cells were dead with no cells remain-
ing attached to the ﬂask. Small discrete colonies formed in the
presence of G418. These colonies grew and propagated in the
presence of G418 indicating that the neomycin resistance gene
present in the RNA replicons was allowing these cells to
survive.3.3. The presence of replicon RNA in replicon transfected cells
To show the presence of replicon RNAs in the transfected
cells, Northern blot analysis was carried out. RNA was ex-
tracted from untransfected Huh7 cells and RNA from Huh7
cells transfected with A1174T (Rep 3) and S1179I (Rep 4).
These RNAs were resolved by formaldehyde gel electrophore-
sis and Northern blot analysis was carried out using a 32P-la-
belled DNA probe corresponding to the NS3 coding region
(Fig. 1). No hybridization signal was detected with RNA
from untransfected Huh7 cells by contrast the cells transfec-
ted with Rep 3 and Rep 4 replicon RNAs both showed
hybridization signals. The signal intensity of hybridization
of Rep 4 RNA with the NS3 probe was greater than that
of Rep 3.
3.4. Expression of NS3 in RNA replicon transfected cells
Replicon cell lines were grown on glass cover slips in six well
plates. When they were 70% conﬂuent, they were ﬁxed and
stained with an anti-NS3 speciﬁc antibody (NS3–7). Untrans-
fected Huh7 cells were also used as a negative control. The cells
were examined using immunoﬂuorescence microscopy. The
Rep 4 cells showed staining indicating the presence of NS3
(Fig. 3A) while the untransfected Huh7 cells showed no stain-
ing for NS3 (Fig. 2B).
It was found that NS3 was mainly localized in the cytoplasm
(Fig. 3A) however, in some cases, it was found in both the cyto-
plasm and the nucleus (Fig. 3B) (Errington et al., 1999).
4. Discussion
To make cell lines which contain RNA replicons, plasmids
which contain the sequence of RNA replicons were transcribed
to produce replicon RNA. The resulting RNA transcripts were
analyzed by gel electrophoresis to ensure that the correct size
bands had been synthesized and that there was no degradation
of the RNA.
Figure 2 Expression of NS3 in RNA replicon transfected cells. (A) Rep 4. (B) Untransfected Huh7.
Figure 3 Localization of HCV NS3 into the cells. (A) Perinuclear localization of NS3 and no nuclear translocation was there as
indicated by the arrow. (B) Translocation of HCV NS3 to the nucleus as shown by the arrow. However, perinuclear localization is clearly
also seen as granules.
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formed in two ways, electroporation and lipofectin. Both proce-
dures had to be performed as rapidly as possible to avoid RNA
degradation. The results showed that both lipofectin transfec-
tion and electroporation were successful in transforming cellswith replicon RNA. With the transfection by electroporation,
it was also important that a high concentration of cells was used
since a large number of the cells died during the electrical pulse.
Twenty-four hours after adding G418, untransfected cells
started to die. After few days, small colonies of transfected
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3 weeks later, the colonies had proliferated and had become
conﬂuent. Subsequent to this, the transformed cells could be
propagated in new culture ﬂasks.
Although transfection and selection of G418 resistant cells
was successful, conﬁrmatory tests were performed to show the
presence of replicon RNA. Northern blot analysis of RNA
from the replicon cell lines using a DNA probe corresponding
to the NS3 region of HCV-1b showed the presence of labelled
bands corresponding to the predicted size of the replicon
RNA.
During the propagation of Huh7 cells transfected with
replicon RNA, it was noticed that they grew slower than
untransfected Huh7 cells grown in the absence of G418. This
may due to the presence of HCV RNA replicating in transfec-
ted cells which may reduce the capacity of the cells to repli-
cate as efﬁciently (Bartenschlager et al., 2003). Also when
comparing the growth rate of the transfected cells, it was no-
ticed that cells transfected with S1179I (Rep 4) grew slower
than those transfected with A1174T (Rep 3). One possibility
was that the Rep 4 cells might contain more replicon RNA
than those transfected with the Rep 3 cells. Comparisons of
the quantities of HCV RNA in replicon cell lines conﬁrmed
that there was a greater copy number of RNA replicon mol-
ecules in the Rep 4 cells (Fig. 1). It is therefore possible that
more replicon RNA was used in the transfection to produce
Rep 4 cells even though it had been intended that both trans-
fections should have used the same quantity of RNA. It has
previously been reported that replicon cell lines that contain
smaller quantities of replicon RNA usually grow faster than
those that contain higher concentrations and this could ex-
plain the different growth rates of Rep 3 and Rep 4 cells
(Lohmann et al., 1999; Bartenschlager et al., 2003). Another
possible reason for the different growth rates of Rep 3 and
Rep 4 cells, which has been described by several authors,
could be the appearance and selection of mutations in the
replicons which affect replication efﬁciency. These mutations
could be found in any area of HCV non-structural region
but they mainly cluster in certain regions of NS5A (Lohmann
et al., 2003). A second cluster of adaptive mutations has also
been found at the carboxy-terminus of the NS3 serine pro-
teinase domain and at the amino-terminus of the NS3 heli-
case domain (Blight et al., 2003; Lohmann et al., 2003).
However, a comparison of the sequences of the Rep 4 and
Rep 3 replicon RNAs derived from the established cell lines
was not carried out in this study. One other possible reason
for the differences in growth rate of the cell lines could be
due to the permissiveness of the host cells. It has been re-
ported that replicons start off replicating slowly in non-
permissive or semi-permissive cells however, after serial
passage highly permissive cells, in which the replicons repli-
cate more efﬁciently, can be selected (Blight et al., 2003;
Murray et al., 2003).
It was shown previously that RNA replicon cell lines have
to be grown in the presence of selective antibiotic continu-
ously to maintain the replicon. By contrast, in the absence
of the selective antibiotic, a gradual reduction of the replicon
RNA should take place (Pietschmann et al., 2001; Bartensch-
lager et al., 2003). To examine the effect of growing Rep 4
cells in the absence of G418, cells were passaged for three
months without antibiotic selection and in parallel to these,
other cells were passaged with antibiotic selection. RNAswere extracted from the cells grown under both conditions
and the levels of replicon RNA were measured by Real-Time
PCR. The results showed that there was a large reduction in
the quantity of replicon RNA (approximately 92%) in the
cells passaged in the absence of G418. This reduction of rep-
licon RNA highly dependent on the way cells were passaged.
When cells were kept conﬂuent for extended periods, replicon
levels dropped rapidly, whereas a more constant amount of
HCV RNA was found in cells passaged while pre-conﬂuent
(Pietschmann et al., 2001). A possible explanation for this is
that the level of replicon RNA replication in conﬂuent cells
may be reduced compared to actively growing pre-conﬂuent
cells. Therefore, RNA degradation is no longer compensated
by de novo RNA synthesis. Consequently, the drop in the
amount of replicon RNA is highest in cells that are left in a
conﬂuent state for prolonged times (Pietschmann et al.,
2001; Bartenschlager et al., 2003). As a result of these ﬁnd-
ings, the replicon cell lines in our laboratory were regularly
passaged at 70% conﬂuence.
The expression of HCV viral antigens in Rep 4 cells was
also demonstrated by staining for the presence of NS3 with
an anti-NS3 antibody (NS3–7) which showed both cytoplas-
mic and nuclear staining (Errington et al., 1999). Overall the
evidence shows that the transfection of Huh7 cells with HCV
RNA replicons and the selection of transfected replicon cell
lines using G418 were successful.
Evidence from many studies has indicated that HCV NS3 is
likely to have important effects on host cells and on the repli-
cation of HCV RNA (Booth, 1998). In previous studies, anti-
bodies against NS3 were used to demonstrate its expression in
tissue culture cells transfected with the NS3 coding sequence
and in HCV infected human hepatocytes (Errington et al.,
1999). It was found that NS3 was present in the cytoplasm
in most of the cells and in some of the cells NS3 was also in
the nucleus. The NS3 staining, in both the cytoplasm and
the nucleus, was granular in pattern which may indicate a pos-
sible association of NS3 with sub-cellular structures (Errington
et al., 1999).
Although most of the replication processes of HCV virus
take place in the cytoplasm of the cell, the detection of NS3
protein in the nucleus (Errington et al., 1999) suggests that it
may have other functions in addition to those of RNA repli-
cation and polyprotein processing. The presence of NS3 in
the nucleus may be due to its association with cellular pro-
teins. This may explain its association with the cellular tumor
suppressor protein p53 in the nucleus (Ishido et al., 1997;
Booth, 1998). It has also been shown that NS3 contains an
amino acid sequence similar to one found in the regulatory
subunit of protein kinase A (PKA) (Muramatsu et al.,
1997). It was shown that NS3 alters PKA localization to
the nucleus in transfected cells (Borowski et al., 1996). This
suggests the possibility that the presence of NS3 in the nu-
cleus could interfere with host cell signaling processes which
in turn could favor viral persistence.References
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